Marketing-authorisation holder · United States
Bracco
68 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
68 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 68
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CARDIOGEN-8282 n/a · Injectable | Rubidium rb-82 n/a | United States | Marketed | 1989 |
| CARDIOGRAFIN85% · Injectable | Diatrizoate | United States | Not marketed | 1958 |
| CARDIOTEC99m teboroxime kit n/a · Injectable | Technetium tc-99m teboroxime kit n/a | United States | Not marketed | 1990 |
| CHLORMERODRIN HG 197197 0.6-1.4mCi/ML · Injectable | Chlormerodrin hg-197 | United States | Not marketed | 1974 |
| CHOLETEC99m mebrofenin kit n/a · Injectable | Technetium tc-99m mebrofenin kit n/a | United States | Marketed | 1987 |
| CHOLOGRAFIN MEGLUMINE10.3% | 52% · Injectable | Adipiodone | United States | Not marketed | 1954 |
| CHOLOGRAFIN SODIUM20% · Injectable | Adipiodone | United States | Not marketed | 1954 |
| CHOLOVUE40.3% | 9.9% · Injectable | Iodoxamate | United States | Not marketed | 1981 |
| CHROMITOPE SODIUM51 200uCi/ML | 51 2mCi/VIAL · Injectable | Chromate cr-51 | United States | Not marketed | 1971 |
| CYSTOGRAFIN30% · Solution | Diatrizoate | United States | Marketed | 1955 |
| CYSTOGRAFIN DILUTE18% · Solution | Diatrizoate | United States | Marketed | 1955 |
| DIATRIZOATE MEGLUMINE76% · Injectable | Diatrizoate | United States | Not marketed | 1955 |
| E-Z-CAT DRY40% · For suspension | Barium | United States | Not marketed | 2016 |
| E-Z-DISK700mg · Tablet | Barium | United States | Marketed | 2025 |
| E-Z-HD98% · For suspension | Barium | United States | Marketed | 2016 |
| E-Z-PAQUE96% · For suspension | Barium | United States | Marketed | 2016 |
| ENTERO VU 24%24% · Suspension | Barium | United States | Marketed | 2016 |
| GASTROGRAFIN66%; 10% · Solution | Diatrizoate | United States | Marketed | 1958 |
| HIPPUTOPE131 1-2mCi/VIAL · Injectable | Iodohippurate i-131 | United States | Not marketed | 1970 |
| IOMERVU15gm iodine/50ml (300mg iodine/ml) | 17.5gm iodine/50ml (350mg iodine/ml) | 20gm iodine/50ml (400mg iodine/ml) | 25gm iodine/100ml (250mg iodine/ml) | 30gm iodine/100ml (300mg iodine/ml) | 35gm iodine/100ml (350mg iodine/ml) | 40gm iodine/100ml (400mg iodine/ml) | 45gm iodine/150ml (300mg iodine/ml) | 52.5gm iodine/150ml (350mg iodine/ml) | 60gm iodine/150ml (400mg iodine/ml) | 60gm iodine/200ml ( · Solution | Iomeprol | United States | Marketed | 2024 |
| IOMERVU15gm iodine/50ml (300mg iodine/ml) | 17.5gm iodine/50ml (350mg iodine/ml) | 20gm iodine/50ml (400mg iodine/ml) | 25gm iodine/100ml (250mg iodine/ml) | 30gm iodine/100ml (300mg iodine/ml) | 35gm iodine/100ml (350mg iodine/ml) | 40gm iodine/100ml (400mg iodine/ml) | 45gm iodine/150ml (300mg iodine/ml) | 52.5gm iodine/150ml (350mg iodine/ml | 60gm iodine/150ml (400mg iodine/ml) | 60gm iodine/200ml (3 · Solution | Iomeprol | United States | Marketed | 2024 |
| ISOVUE-12826% · Injectable | Iopamidol | United States | Not marketed | 1985 |
| ISOVUE-20041% · Injectable | Iopamidol | United States | Marketed | 1985 |
| ISOVUE-25051% · Injectable | Iopamidol | United States | Marketed | 1985 |
| ISOVUE-30061% · Injectable | Iopamidol | United States | Marketed | 1985 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 68 | 68 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.